Health experts warn of 'walking pneumonia' cases on the rise
FOX31's Kim Posey spoke with a local doctor about the risk of "walking pneumonia" after the CDC warned the public about more ...
Alector: Bleak Prospects After Alzheimer's Failure
Alector has significant cash reserves but faces high cash burn, with no immediate catalysts and uncertain prospects for its ...
Freeman Health System highlights lifesaving lung cancer screenings
Loud noises and aging are widely known to cause hearing loss. However, some life-saving medications could harm your hearing ...
Buy Recommendation for Anavex Life Sciences: Promising Alzheimer’s Treatment and Expanding Clinical Pipeline
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Anavex Life Sciences (AVXL – Research Report) today and set a price target of ...
Pharmabiz19h
Cassava Sciences’ ReThink-ALZ phase 3 study of simufilam in mild-to-moderate AD fails to meet co-primary endpoints
Cassava Sciences, Inc., a clinical-stage biotechnology company focused on developing a novel, investigational treatment for Alzheimer’s disease (AD) dementia, announced that the topline results from ...
ATTENTION SAVA SHAREHOLDERS: Investors who Lost Money on Cassava Sciences, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / November 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cassava ...